Kawasaki Heavy Industries reports Q1 results; raises FY 2026 outlook Source link Like this:Like Loading… Related Post navigation Karman signals $730M-$745M 2026 revenue outlook while targeting 20%-25% annual organic growth (NYSE:KRMN) Nxera Pharma GAAP EPS of ¥15.86, revenue of ¥18.91B; reaffirms FY 2026 outlook